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Fluorescence emission intensity of HF488 labelled Aβ peptides
The emission intensity was measured on 1 µM Aβ solutions to confirm equal emission intensities of the two fluorophore-conjugated Aβ variants at the same peptide concentration (Fig. S1 ). Spectra were recorded in a 60 µl, 3 mm path length, quartz micro-cuvette (Hellma Analytics, Müllheim, Switzerland) using a Varian Eclipse fluorimeter (Agilent Technologies, Santa Clara, CA, US). The samples were excited at 470 nm and the emission was collected between 480-700 nm. Figure S1 . Emission spectra of HF488 labelled and at a peptide concentration of 1 µM. The data is presented as average fluorescence emission intensity of two aliquots each of and .
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Calibration curve for quantification of amyloid-β in SH-SY5Y cells
Quantification of intracellular Aβ(1-40) and Aβ(1-42) was performed using confocal imaging, through establishment of a calibration curve using Aβ solutions with known concentrations ranging from 0-10 μM. The procedures are described in the Methods section of the main text.
The calculated average pixel intensity as a function of peptide concentration is shown in Fig.   S2 . The images were recorded with a pixel size of 152 nm*152 nm and a probe depth of 1.85 μm (corresponding to 2.5 axial voxels). Using these numbers, the average pixel intensity was translated to a mean intensity per Aβ molecule of 5.67. This value was thereafter used to quantify cellular uptake as displayed in Fig. 1D 
Identification of the live cell cluster for flow cytometry analysis
In the quantitative peptide uptake experiments analysed by flow cytometry it was advantageous to only include viable cells in the analysis, as dead cells could have compromised membranes that may influence the extent of uptake, thereby biasing the results. It was also important to establish an experimental treatment window for endocytosis perturbation, whereby the inhibitors had significant effects without being highly cytotoxic. Supplementary Fig. S3A-B shows the localisation of live and dead cells on flow cytometry FSC/SSC dot-plots. The gate corresponding to live cells was set based on the cluster of untreated cells ( Supplementary Fig.   S3A ), whereas the gate corresponding to dead cells was based on the main cluster following treatment with 0.1% H2O2 (Supplementary Fig. S3B ). Cells were also stained with calcein-AM (live stain) and propidium iodide (dead stain). The corresponding intensity histograms confirmed the position of the live and dead gates ( Supplementary Fig. S3C-D) . Only cells within the live gate were analysed in the quantitative uptake experiments. Treatment with Aβ alone at the concentration and incubation times used in this study did not result in an apparent shift of the cell population in the FSC/SSC dot-plots. The cell cluster is still concerted and localised to the live cell gate after a 5 h incubation with 1 μM Aβ ( Supplementary Fig. S4 ). 
Optimisation of protocols for perturbation of endocytosis
The endocytosis inhibitors used in this study were toxic at high concentrations and/or prolonged incubation, therefore protocols needed to be optimized to find conditions where endocytosis was perturbed without concomitant cytotoxic effects. Optimisation was performed using the live/dead gates defined in Supplementary Fig. S3 . Supplementary Fig. S5 shows FSC/SSC dotplots corresponding to the treatment conditions applied for endocytosis perturbation (Fig. 2-5 ). 
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Supplementary Figure S5. Flow cytometry FSC/SSC dot-plots of cell samples treated with the different endocytosis inhibitors used in this study. Data were recorded after the cells had been treated with inhibitors for the same duration of time as in the peptide incubation experiments. (A) ATP depletion solution 3 h, (B) ATP depletion 3 h followed by recovery 2 h, (C) cytochalasin A 10µM 90 min, (D) cytochalasin D 25µg/ml 90 min, (E) IPA-3 10 µM 90 min, (F) wortmannin
Control for the transferrin pulse addition following endocytosis perturbation
The timespans of cell treatment with transferrin (Trf) (5 min) and Aβ (60 min) during endocytosis perturbation are different and effect the total time that cells are exposed to endocytosis inhibitors. We hypothesized that this may influence relative uptake as prolonged inhibitor exposure might lead to toxic effects. To test this, Trf was added in a 5 min pulse immediately after a 30 min pre-treatment period with each inhibitor, or following a 60 min pretreatment as schematically depicted in Supplementary Fig. S6A . We compared Trf uptake in control samples (0.08% DMSO), in cells treated with the macropinocytosis inhibitor IPA-3 (Trf uptake should be unaffected) and in cells treated with dynamin inhibitor dynasore (Trf uptake should be affected) ( Supplementary Fig. S6B ). None or only minor effects could be observed, suggesting that toxicity due to the inhibitor does not develop during the 60 min incubation time window used for peptide incubations in this study. It was hence concluded Trf can be used as control for inhibition specificity, regardless of the pre-treatment duration. 
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Optimisation of CPZ concentration and inhibition of clathrin mediated endocytosis including control samples
Since CPZ was found to be rapidly degraded in aqueous solutions, we optimised the concentration of this inhibitor by adding the Trf 5-min-pulse to cells which had already been treated with Aβ for 1 h, and thereafter followed the protocol for Trf treated cells as described in the Methods section. In doing so, we avoided the risk of the inhibitor being degraded during the experiment day. The results are depicted in Supplementary Fig. S7 . Based on the plateauing effect in the reduction of Trf uptake, a concentration of 5 µg/ml CPZ was chosen for further experiments. 
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